American Century Disciplined Growth R holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
American Century Disciplined Growth Fund Class R ADRRX
- NAV / 1-Day Return 20.77 / −0.96 %
- Total Assets 464.3M
-
Adj. Expense Ratio
1.410%
- Expense Ratio 1.420%
- Distribution Fee Level High
- Share Class Type Retirement, Medium
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 57%
USD | NAV as of Jun 16, 2026 | 1-Day Return as of Jun 16, 2026, 8:39 PM GMT+0
Morningstar’s Analysis ADRRX
Will ADRRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the ADRRX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of ADRRX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 53.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
NVIDIA Corp | 12.34 | 51M | Technology |
Apple Inc | 12.02 | 49M | Technology |
Microsoft Corp | 6.61 | 27M | Technology |
Broadcom Inc | 4.68 | 19M | Technology |
Amazon.com Inc | 3.90 | 16M | Consumer Cyclical |
Meta Platforms Inc Class A | 3.27 | 13M | Communication Services |
Alphabet Inc Class C | 3.06 | 13M | Communication Services |
Alphabet Inc Class A | 2.63 | 11M | Communication Services |
Tesla Inc | 2.52 | 10M | Consumer Cyclical |
AbbVie Inc | 2.46 | 10M | Healthcare |
United States